S&P also assigned a “BBB-” long-term rating to the health system’s $915 million of series 2017 fixed-rate bonds.
“The rating action primarily reflects our view of MetroHealth’s large capital project and the related increased pro forma debt levels from the series 2017 issuance coupled with an existing financial profile that we consider somewhat light,” said S&P analyst Suzie Desai.
The outlook is stable, reflecting S&P Global Ratings’ opinion the health system will return to operating stability through interim 2017 with the implementation of several key initiatives.
More articles on healthcare finance:
9 recent hospital outlook and credit rating actions
Moody’s affirms ‘A2’ rating on Greater Baltimore Medical Center’s bonds
Letter to the editor: Cigarette tax is key for our community
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.